NCT01602913 - Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine | Biotech Hunter

Enrollment

1

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Depression, Postpartum

Interventions

DRUG

Pravastatin alone

Pravastatin is a member of the drug class of statins, also known as HMG-CoA reductase inhibitors, and is known to reduce the amount of cholesterol and other fatty substances in the blood. In addition, pravastatin is indicated to reduce the risk of myocardial infarction, revascularization and cardiovascular mortality in hypercholesterolemic patients who do not have clinically apparent coronary heart disease.

DRUG

Paroxetine alone

Paroxetine is an orally administered selective serotonin reuptake inhibitor (SSRI) for the treatment of depression

DRUG

Pravastatin and paroxetine combined

Pravastatin is a member of the drug class of statins, also known as HMG-CoA reductase inhibitors, and is known to reduce the amount of cholesterol and other fatty substances in the blood. In addition, pravastatin is indicated to reduce the risk of myocardial infarction, revascularization and cardiovascular mortality in hypercholesterolemic patients who do not have clinically apparent coronary heart disease. Paroxetine is an orally administered selective serotonin reuptake inhibitor (SSRI) for the treatment of depression